Vasectomy and human immunodeficiency virus type 1 in semen. 1998

J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
Department of Urology, University of Washington School of Medicine, Seattle, USA.

OBJECTIVE Human immunodeficiency virus type 1 (HIV) is cultured more often from seminal cells than seminal plasma. Because vasectomy causes dramatic reductions in seminal cells and also eliminates secretions from proximal sites in the male reproductive tract, vasectomy may change the potential infectiousness of semen. METHODS We used polymerase chain reaction (PCR) assays to measure HIV ribonucleic acid (RNA) in seminal plasma and HIV deoxyribonucleic acid (DNA) in seminal cells from 46 asymptomatic, seropositive men before and after vasectomy. RESULTS HIV RNA levels in semen correlated only weakly with blood levels (r = 0.22, p = 0.03). Of 183 semen specimens assayed for cell-free HIV RNA and proviral DNA 37 (20%) were positive for HIV RNA only, 41 (22%) were positive for HIV DNA only, and 18 (10%) were positive for RNA and DNA. Thus, detection of HIV RNA in seminal plasma was not associated with detection of HIV DNA in seminal cells. HIV RNA was present in 23 of 82 specimens (28%) (mean 2.87 log copies/ml.) before vasectomy and in 38 of 121 specimens (31%) after vasectomy (mean 2.81 log copies/ml.). CONCLUSIONS These findings suggest that direct measurement of HIV levels in semen is necessary to assess the potential for sexual transmission, most cell-free HIV in seminal plasma arises distal to the vas deferens, and vasectomy may have minimal impact on the infectiousness of HIV seropositive men on sexual partners.

UI MeSH Term Description Entries
D008297 Male Males
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012661 Semen The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma. Seminal Plasma,Plasma, Seminal
D014659 Vasectomy Surgical removal of the ductus deferens, or a portion of it. It is done in association with prostatectomy, or to induce infertility. (Dorland, 28th ed) Intravasal Thread,Vas Ligation,Vas Occlusion,Vas Occlusion, Nonchemical,Vasectomy Seekers,Vasectomy Seekers, Refused,Intravasal Threads,Ligation, Vas,Ligations, Vas,Nonchemical Vas Occlusion,Nonchemical Vas Occlusions,Occlusion, Nonchemical Vas,Occlusion, Vas,Occlusions, Nonchemical Vas,Occlusions, Vas,Refused Vasectomy Seeker,Refused Vasectomy Seekers,Seeker, Refused Vasectomy,Seeker, Vasectomy,Seekers, Refused Vasectomy,Seekers, Vasectomy,Thread, Intravasal,Threads, Intravasal,Vas Ligations,Vas Occlusions,Vas Occlusions, Nonchemical,Vasectomies,Vasectomy Seeker,Vasectomy Seeker, Refused
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
October 2005, AIDS research and therapy,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
January 1998, Journal of virology,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
February 2005, Journal of virology,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
January 2005, Methods in molecular biology (Clifton, N.J.),
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
October 1997, The Journal of infectious diseases,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
December 2004, Human reproduction (Oxford, England),
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
August 1999, Antimicrobial agents and chemotherapy,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
December 1998, The New England journal of medicine,
J N Krieger, and A Nirapathpongporn, and M Chaiyaporn, and G Peterson, and I Nikolaeva, and R Akridge, and S O Ross, and R W Coombs
April 1993, The Journal of infectious diseases,
Copied contents to your clipboard!